Welcome to our dedicated page for AMPHENOL /DE/ SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMPHENOL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMPHENOL /DE/'s regulatory disclosures and financial reporting.
Amphenol Corp President & CEO Richard Adam Norwitt reported a new stock option grant on Class A Common Stock. He received options covering 464,989 shares at an exercise price of 132.06 per share, exercisable starting on the first anniversary of the grant date.
According to the filing, the options vest at 20% per year over five years and expire on May 22, 2036. The report also lists existing holdings of Class A Common Stock held directly, indirectly through the Norwitt Family Trust, and some shares owned through his IRA, with no open-market buys or sells disclosed.
Amphenol Executive VP & CFO Craig A. Lampo reported updated holdings and a new equity award. He received a grant of 133,161 stock options on Class A Common Stock at an exercise price of $132.06 per share, expiring in 2036. The options begin to vest 20% per year over five years starting on the first anniversary of the grant date, aligning compensation with longer-term performance. The filing also lists his direct holding of 70,907 Class A shares and additional indirect holdings through several GRAT entities.
Ivas Michael R. reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corp senior vice president and corporate controller Michael R. Ivas reported a new stock option grant linked to the company’s Class A Common Stock. He received options covering 51,134 shares, exercisable at $132.06 per share, expiring in 2036.
According to the footnote, these options become exercisable at 20% per year over five years, starting on the first anniversary of the grant date. The filing also lists his existing share positions, including 154,948 shares held directly and additional indirect holdings through his spouse, children, and a 2026 GRAT.
Amphenol Corp executive William J. Doherty, President of the CS Division, received a grant of stock options as part of his compensation. He was awarded 108,809 stock options, each giving the right to buy one share of Class A Common Stock at an exercise price of $132.06 per share.
The options start to become exercisable at a rate of 20% per year over five years, beginning on the first anniversary of the grant date, and will expire on May 22, 2036. The filing also shows that Doherty held 0 shares of Class A Common Stock directly after the reported transactions.
Amphenol EVP and General Counsel Lance E. D'Amico received a stock option award tied to the company’s Class A Common Stock. On May 22, 2026, he was granted options for 83,020 shares at an exercise price of $132.06 per share, vesting 20% per year over five years starting one year after the grant date and expiring on May 22, 2036.
Following this filing, D'Amico is reported as holding 57,065 shares of Class A Common Stock directly, plus 25,000 shares and 19,335 shares indirectly through the Lance E. D'Amico 2026 GRAT #1 and 2025 GRAT #1, respectively.
Wolff Anne Clarke reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Anne Clarke Wolff received a grant of 1,552 shares of Restricted Stock. The award was granted on May 22, 2026 at a stated price of $0.0000 per share as compensation, not a market purchase.
The grant was made under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. Following this award, Wolff directly holds 1,552 shares of Restricted Stock and 41,154 shares of Class A Common Stock reported as a holding entry.
Singh Prahlad R. reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Prahlad R. Singh received a grant of 1,552 shares of Restricted Stock. The award was granted at a price of $0.0000 per share under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
Following this filing, Singh holds 11,376 shares of Class A Common Stock directly and 1,552 shares of Restricted Stock directly. The grant reflects equity-based compensation for his role as a director rather than an open-market purchase or sale.
Livingston Robert reported acquisition or exercise transactions in this Form 4 filing.
Amphenol director Robert Livingston received an award of 1,552 shares of Restricted Stock on May 22, 2026. The grant was made at $0.00 per share as a compensation award under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation.
Following the transactions reported, Livingston directly holds 138,080 shares of Class A Common Stock and 1,552 shares of Restricted Stock. The filing reflects a stock grant rather than any open‑market buying or selling activity.
Amphenol director Rita S. Lane reported a new equity award and updated holdings. She received 1,552 shares of Restricted Stock of Amphenol Corporation on May 22, 2026 as a grant under the 2024 Restricted Stock Plan for Directors, with no purchase price paid.
Following this award, Lane holds 9,840 shares of Class A Common Stock directly and 15,006 shares indirectly through the Fries Lane Family Living Trust, along with the 1,552 restricted shares. This filing reflects a compensation-related acquisition rather than an open-market transaction.
Lamba Sanjiv reported acquisition or exercise transactions in this Form 4 filing.
Amphenol Corporation director Sanjiv Lamba reported an equity compensation grant and his existing share holdings. On May 22, 2026, he received 1,552 shares of Restricted Stock as a grant under the 2024 Restricted Stock Plan for Directors of Amphenol Corporation. A separate line shows he directly holds 548 shares of Class A Common Stock after the reported transactions.